|
Role
Mary C. Tanner is a Managing Director of Peter J. Solomon Company and joined the firm in 2009. She is a member of its Mergers and Acquisitions Group and with Vice Chairman Fred Frank, co-heads PJSC’s global pharmaceutical and life sciences practice.
Experience
Prior to joining PJSC, Ms. Tanner headed Life Sciences Partners, a company she founded to specialize in healthcare investment and strategic advisory work. Previously, she served as Senior Managing Director at both Lehman Brothers and Bear Stearns. Ms. Tanner has devoted more than 25 years to the global healthcare industry. Her expertise includes the ethical pharmaceutical industry, biotechnology, diagnostics, medical devices, healthcare services, cosmetics and consumer medicine industries. In addition to her well-known work with large companies, Ms. Tanner specializes in domestic and cross-border transactions between large and small companies, including corporate partnering and minority investments. A few of Ms. Tanner’s clients have included: Pfizer in its $60B acquisition of Pharmacia; Amgen in its $16B acquisition of Immunex; Rhone-Poulenc in its acquisition of Rorer; then Rhone-Poulenc Rorer in its acquisition of UK company Fisons; BASF/BASF Pharma, a German company, in its acquisition of UK company Boots Pharmaceuticals.
Professional Affiliations
Director, Evotec AG
Director, Synvista Therapeutics
Director, Acute Pain Therapy, Ltd
Not-For-Profit Affiliations
Member, Dean’s Council, Yale School of Medicine
Academic Credentials
Ms. Tanner received a B.A. from Harvard University.
Back to Our People |
